<PAGE>
Exhibit 10.3
Schedule 4.16
PATENT STATUS OF BLSI TECHNOLOGIES
<TABLE>
<CAPTION>
Schedule 4.16
Application
Year Year Serial Patent
Technology filed issued Number Number Title Comments
====================================================================================================================================
<S> <C> <C> <C> <C> <C> <C>
Therafectin N/A 1994 N/A 5,298,494 Monosaccharides having anti-proliferation and
anti-inflammatory activity,
compositions and uses thereof Use/manufacturing
------------------------------------------------------------------------------------------------------------------------------------
Altropane N/A 1996 N/A 5,493,026 Substituted 2-Carboxyalkyl-3-(Flurophenyl)-8-
(3-Halopropen-2-YL) Nortropanes Composition
and their use as imaging for neurodegenerative disorders
------------------------------------------------------------------------------------------------------------------------------------
Troponin N/A 1998 N/A 5,837,680 Pharmaceutical compositions comprising troponin subunits,
fragments and analogs thereof and methods of Use
their use to inhibit angiogenesis
------------------------------------------------------------------------------------------------------------------------------------
AF-1 1997 08/916,642 Trophic factors for CNS Regeneration Use/composition
------------------------------------------------------------------------------------------------------------------------------------
Inosine 1997 08/921,902 Methods for Modulating the Axonal Outgrowth of CNS Neurons Use
------------------------------------------------------------------------------------------------------------------------------------
C-maf 1996 08/636,602 Methods and Compositions for Regulating T-cell subsets Composition/Use
by Modulating Transcription Factor Activity
------------------------------------------------------------------------------------------------------------------------------------
</TABLE>
All patents have been filed and maintained in all major territories worldwide.
In the case of issued patents, these refer to US only. Foreign patents have not
yet been issued.
